Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46th Annual TD Cowen Healthcare Conference in Boston. Pulse Biosciences’ Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm … [Read more…]

FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia

– First and only all-oral, fixed-duration regimen designed to provide CLL patients with the potential to experience time off treatment – – Approval expands Genentech’s fixed-duration portfolio by providing eligible first-line patients another option alongside the established Venclexta plus Gazyva regimen – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, … [Read more…]

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D

TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (TSE: 4568) has appointed John Tsai, MD to succeed Ken Takeshita, MD, who is stepping down as Global Head of R&D, effective April 1, 2026. Dr. Tsai will bring more than 25 years of proven leadership and experience driving innovation to further grow the rich Daiichi … [Read more…]

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results … [Read more…]

Animate Biosciences Reports Preclinical Data Showing Dramatic Reduction in Cardiac Scarring and Near-Doubling of Heart Function After Experimental Heart Attack

Single-dose designed peptide drives structural and functional cardiac repair in a mouse myocardial infarction model SAN FRANCISCO–(BUSINESS WIRE)–Animate Biosciences, a biotechnology company focused on designing innovative peptide therapeutics, today announces positive preclinical results demonstrating that its lead therapeutic peptide, MBb32, produced a significant reduction in cardiac scar tissue (infarct) and subsequent recovery of heart function … [Read more…]

United Aesthetics Alliance Announces Partnership With LivSkin MedSpa | Laser

MINNEAPOLIS–(BUSINESS WIRE)–United Aesthetics Alliance (“UAA” or the “Company”), a leading platform of plastic surgery practices and medical spa brands, today announced its partnership with LivSkin MedSpa | Laser (“LivSkin”), a medical spa industry leader in anti-aging products and procedures based in Minneapolis. The transaction represents a significant strategic acquisition that further strengthens UAA’s presence in … [Read more…]

Millennium Systems International Introduces MeevoPay Giving, Enabling Seamless Checkout Donations for Salons, Spas, and Med Spas

PARSIPPANY, N.J.–(BUSINESS WIRE)–Millennium Systems International (MSI), the maker of Meevo, the award-winning salon, spa, and med spa software platform, announced today the launch of MeevoPay Giving, a new capability that allows businesses using MeevoPay to offer guests the option to make a charitable donation to industry nonprofits directly at checkout. MeevoPay Giving was created on … [Read more…]

From Chile’s Forests to Fields, Syngenta Brings Botanical-Based Biofungicide to the Americas

BASEL, Chile & DAVIS, Calif.–(BUSINESS WIRE)–Innovation often begins by observing nature and drawing inspiration from it, a wisdom deeply rooted in the ancient Mapuche culture of Chile. Known and used for centuries, the Mapuche have traditionally utilized the bark’s high saponin content of Quillaja saponaria for cleansing and medicinal purposes, and today this ever-green tree … [Read more…]

Materialise Reports Fourth Quarter and Full Year 2025 Results

Regulated information1 LEUVEN, Belgium–(BUSINESS WIRE)–$MTLS–Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 … [Read more…]

Compass Pathways Announces Pricing of $150 Million Public Offering

LONDON & NEW YORK–(BUSINESS WIRE)–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain … [Read more…]